Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have primary myelodysplastic syndrome.

Timeline

Start

1999-02

Primary completion

—

Completion

—

Drugs

Indications